Why Healthpeak Properties (DOC) Is Getting Attention Today
Healthpeak Properties (DOC) has put income front and center again after its board declared a monthly common stock dividend of $0.10167 per share for the fourth quarter of 2026.
At a share price of $18.80, Healthpeak Properties has seen short term momentum soften, with the 30 day share price return down 7.8% and the 90 day move down 13.2%. This is even though the year to date share price return is 16.1% and the 3 year total shareholder return is 31.2%.
Scan beyond Healthpeak Properties to compare this dividend move with other income-focused REITs and yield plays in the 8 dividend fortresses.
Healthpeak Properties now trades well below both analyst targets and one intrinsic value estimate, despite that recent pullback. Where does fair value actually line up inside that spread, and how much gap is left to explain?
Most Popular Narrative: 18% Undervalued
Against the last close of $18.80, the most followed narrative pegs Healthpeak Properties' fair value at $23.05. This frames that recent drop as a valuation gap rather than just sentiment noise.
The accelerating shift of surgical and specialty care from inpatient hospital settings to outpatient centers, supported by anticipated regulatory changes (CMS inpatient-only default reversal), is set to drive sustained tenant demand and pricing power for Healthpeak's modern, high-acuity outpatient medical buildings, which should translate into increased occupancy rates and same-store NOI growth.
See why 34 investors see Healthpeak Properties as 18% undervalued.
Result: Fair Value of $23.05 (UNDERVALUED)
Still, the Healthpeak Properties story carries pressure points, including concentrated exposure to biotech tenants and key outpatient hubs where weaker demand or oversupply could quickly challenge that undervaluation thesis.
Find out about the key risks to this Healthpeak Properties narrative.
Next Steps
Mixed signals around Healthpeak Properties can be confusing, so it is important to move quickly, review the full data set, and weigh both the 3 key rewards and 4 important warning signs.
Looking for more investment ideas beyond Healthpeak Properties?
If you only stop at Healthpeak Properties, you risk missing other opportunities that match your goals, risk appetite, and income needs across the wider market.
- Target resilient balance sheets by scanning companies with strong fundamentals using the list of solid balance sheet and fundamentals (25 results).
- Hunt for potential mispricings across the market with the 28 high quality undervalued stocks that highlights quality businesses trading below one estimate of fair value.
- Prioritise reliable income streams by reviewing high yielding opportunities curated in the 8 dividend fortresses.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com